Rankings
▼
Calendar
IMA Q4 2023 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena
IMA
ImageneBio Inc
$67M
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$659,000
-87.9% YoY
Gross Profit
$354,000
53.7% margin
Operating Income
-$22M
-3324.4% margin
Net Income
-$19M
-2957.4% margin
EPS (Diluted)
$-0.41
QoQ Revenue Growth
-44.4%
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$192M
Total Liabilities
$22M
Stockholders' Equity
$170M
Cash & Equivalents
$120M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$659,000
$5M
-87.9%
Gross Profit
$354,000
-$10M
+103.5%
Operating Income
-$22M
-$15M
-45.0%
Net Income
-$19M
-$14M
-38.2%
← FY 2023
All Quarters
Q1 2024 →